Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Report

White Paper_2017_State of China Life Science

State of China Life Science - 2017H1

Over $10B invested in last 18 months! Download free report on life science investment in China.

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Week in Review: Zai Lab Completes $150 Million US IPO; Investors Push Valuation to $1.4 Billion
Zai Labs Completes $150 Million IPO; Stock Jumps 50% at Opening; Company Worth $1.4 Billion
Week in Review: Shanghai United Imaging Raises $500 Million in Series A; Zai Lab will IPO Next Week
Week in Review: China Pharma Continues Record Deal Pace with $2 Billion in New Announcements
Week in Review: Columbia China Building $150 Million Hospital in Jiaxing
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China